Hypobetalipoproteinaemia secondary to chronic hepatitis C virus infection in a patient with familial hypercholesterolaemia

Annals of Clinical Biochemistry

Volumn 46, Issue 5, 2009, Pages 420-422

  Bima, Abdulhadi I ^a   Hooper, Amanda J ^a,b   Van Bockxmeer, Frank M ^c   Burnett, John R ^a,b,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; APOLIPOPROTEIN B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CACHEXIA; CASE REPORT; CORONARY ARTERY DISEASE; DNA SEQUENCE; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; GENOTYPE; HEPATITIS C; HETEROZYGOTE; HUMAN; HYPERTHYROIDISM; HYPOBETALIPOPROTEINEMIA; LIVER DISEASE; MALABSORPTION; MALE; MALNUTRITION; PRIORITY JOURNAL; VEGETARIAN DIET;

ADULT; DNA MUTATIONAL ANALYSIS; HEPATITIS C, CHRONIC; HETEROZYGOTE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE II; MALE; RECEPTORS, LDL;

HEPATITIS C VIRUS;

EID: 69749113374     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2009.009004     Document Type: Article

References (18)

1. Bhatnagar D. Diagnosis and screening for familial hypercholesterolaemia: finding the patients, finding the genes. Ann Clin Biochem 2006;43:441-456 (Pubitemid 44808269)
2. Burnett JR, Hooper AJ. Common and rare gene variants affecting plasma LDL. Clin Biochem Rev 2008;29:11-25
3. Gillett MJ, Burnett JR. Manifestations of familial hypercholesterolaemia. Intern Med J 2005;35:63-64
4. Burnett JR, Ravine D, van Bockxmeer FM, Watts GF. Familial hypercholesterolaemia: a look back, a look ahead. Med J Aust 2005;182:552-553 (Pubitemid 40823469)
5. Hadfield SG, Humphries SE. Implementation of cascade screening for the detection of familial hypercholesterolaemia. Curr Opin Lipidol 2005;16:428-433 (Pubitemid 41017627)
6. Hadfield SG, Horara S, Starr BJ, et al. Family tracing to identify patients with familial hypercholesterolaemia: the second audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project. Ann Clin Biochem 2009;46:24-32
7. Whitfield AJ, Barrett PHR, van Bockxmeer FM, Burnett JR. Lipid disorders and mutations in the APOB gene. Clin Chem 2004;50:1725-1732
8. Hooper AJ, van Bockxmeer FM, Burnett JR. Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism. Crit Rev Clin Lab Sci 2005;42:515-545 (Pubitemid 43068251)
9. Mengshol JA, Golden-Mason L, Rosen HR. Mechanisms of Disease: HCV-induced liver injury. Nat Clin Pract Gastroenterol Hepatol 2007;4:622-634 (Pubitemid 350055563)
10. André P, Perlemuter G, Budkowska A, Bréchot C, Lotteau V. Hepatitis C virus particles and lipoprotein metabolism. Semin Liver Dis 2005;25:93-104 (Pubitemid 40322354)
11. Monazahian M, Kippenberger S, Müller A, et al. Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus. Med Microbiol Immunol 2000;188:177-184 (Pubitemid 30411667)
12. Perlemuter G, Sabile A, Letteron P, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002;16:185-194 (Pubitemid 34113012)
13. Mirandola S, Realdon S, Iqbal J, et al. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 2006;130:1661-1669 (Pubitemid 43668848)
14. Burnett JR, Barrett PHR. Apolipoprotein B metabolism: tracer kinetics, models and metabolic studies. Crit Rev Clin Lab Sci 2002;39:89-137
15. Petit JM, Benichou M, Duvillard L, et al. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. Am J Gastroenterol 2003;98:1150-1154 (Pubitemid 36733780)
16. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992;1:445-466
17. Poynard T, Ratziu V, McHutchison J, et al. Effect of treatment with peginterferon or interon alfa-2b and ribaviron on steatosis in patients infected with hepatitis C. Hepatology 2003;38:75-85 (Pubitemid 36775798)
18. Huang H, Sun F, Owen DM, et al. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci USA 2007;104:5848-5853 (Pubitemid 47175622)